---
document_datetime: 2025-04-03 16:08:01
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/ronapreve-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: ronapreve-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 4.6154202
conversion_datetime: 2025-12-24 16:12:27.64818
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Ronapreve

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency' s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessmenthistory'section.Forthecompleteproductlifecycleprocedures,pleasealsorefertoEPAR-Proceduralstepstakenandscientific information after authorisation (archive).

| Applicationnumber   | Scope                                  | Opinion/ Notification 1 issued on   | Commission Decision Issued2/ amended on   | Product Information affected3   | Summary   |
|---------------------|----------------------------------------|-------------------------------------|-------------------------------------------|---------------------------------|-----------|
| Variation type IA / | This was an application for a group of | 03/04/2025                          | N/A                                       | Annex II                        |           |

SendusaquestionGotowww.ema.europa.eu/contactTelephone+31(0)887816000

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000254621                   | variationsfollowing a worksharingprocedure according to Article 20 of Commission Regulation(EC)No 1234/2008. A.5 Change in the name and/or address of a manufacturer/importerof thefinished product (including batch release or quality control testing sites)-A.5.b The activities for which the manufacturer/importer is responsibledonotincludebatchrelease- Accepted A.ADMINISTRATIVECHANGES-A.4Change in thename and/or addressof:a manufacturer(includingwhererelevant quality control testing sites); or an ASMF holder; or a supplier of the active substance, startingmaterial,reagentorintermediate usedinthemanufactureof theactive substance(where specified inthetechnical dossier)where noPh.Eur.Certificate of Suitability is part of the approved dossier; or a manufacturer of a novel excipient (where specified in the technical dossier) - Accepted   |            |     |
|-------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| Variation typeIA/ EMA/VR/0000240448 | Thiswas anapplicationfor a group of variationsfollowingaworksharingprocedure accordingtoArticle20ofCommission Regulation (EC) No 1234/2008. A.5Change in the name and/or address of a manufacturer/importer of thefinished                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 21/01/2025 | N/A |

<div style=\"page-break-after: always\"></div>

| product (including batch release or quality control testing sites)-A.5.b The activities for which the manufacturer/importer is responsibledonotincludebatchrelease- Refused A. ADMINISTRATIVE CHANGES -A.4 Change in the name and/or address of: a manufacturer (including where relevant quality control testing sites); or an ASMF holder; or a supplier of the active substance, startingmaterial,reagentorintermediate usedinthemanufactureof theactive substance(where specified in thetechnical dossier)where noPh.Eur.Certificate of Suitability is part of the approved dossier; or a manufacturer of a novel excipient (where specified in the technical dossier)- Refused   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|